A very impressive study for how we could prevent lung cancer more than 5 years before it is diagnosed. Using machine learning, discovery of a 14-plasma protein signature of risk that predicts responsiveness to an antibody therapy to interleukin, IL-1β
Validated across 8 cohorts
HEALTHCARE AI
-
Machine learning identifies 14-protein signature predicting lung cancer risk and therapy response.
By
–
-
Administration working on pathway to regulate independent AI doctors
By
–
"Administration figures are working a pathway to regulate independent AI doctors." by @lizzadwoskin gift link https://
wapo.st/4x74KaP -
Caution needed in interim years for biorisk despite potential gains
By
–
And there is a real chance that powerful capabilities make us better in the long term on biorisk but I’d really like to see the long-term arrive so, in these weird interim years when we have humans eyeballing proteins, let’s be a wee bit careful.
-
AI Could Cure Diseases, Fight Climate Change, and Make Work Meaningful
By
–
AI could cure diseases, help fight climate change, and even make our jobs more meaningful. None of this is guaranteed, but these are seven of the greatest hopes for AI.
— Bernard Marr (@BernardMarr) 4 juin 2026
7 Ways AI Could Change the World:
1️⃣ More Meaningful Work – AI handles the boring stuff like resetting… pic.twitter.com/RMAFt7GJyoAI could cure diseases, help fight climate change, and even make our jobs more meaningful. None of this is guaranteed, but these are seven of the greatest hopes for AI. 7 Ways AI Could Change the World: More Meaningful Work – AI handles the boring stuff like resetting
-
Major GPT-Rosalind Upgrade for Enhanced Drug Discovery and Design
By
–
Major upgrade to GPT-Rosalind, with much better intelligence for drug discovery, analysis, design, and experimental workflows:
-
OpenAI adds new capabilities to GPT-Rosalind for drug discovery
By
–
We’re bringing new capabilities to GPT-Rosalind, a model series purpose-built for life sciences research at enterprise scale. It brings GPT-5.5’s agentic coding and tool use together with stronger intelligence for drug discovery, analysis, design, and experimental workflows.
-
AI Reshaping Life Sciences: Designing Proteins and Decoding Brain
By
–
At the AI+Science conference, @StanfordHAI Associate Director and Senior Fellow @RBAltman moderated a panel that explored how AI is reshaping the life sciences — from designing novel proteins to decoding the brain's computational architecture. Catch his key insight from the panel… pic.twitter.com/Byr0YNrk4M
— Stanford HAI (@StanfordHAI) 3 juin 2026At the AI+Science conference, @StanfordHAI Associate Director and Senior Fellow @RBAltman moderated a panel that explored how AI is reshaping the life sciences — from designing novel proteins to decoding the brain's computational architecture. Catch his key insight from the panel
-
Compliant AI systems reduce risk for students and researchers
By
–
Not to mention that having HIPAA and FERPA compliant AI systems makes thousands of students and researchers using them less risky.
-
Mayo Clinic and Microsoft partner on frontier AI model for healthcare
By
–
Proud that we’re collaborating with Mayo Clinic to build a frontier AI model for healthcare. Both our organizations exist to serve people at scale – and we believe this could be nothing short of transformative for global healthcare. https://
news.microsoft.com/source/2026/06
/02/mayo-clinic-and-microsoft-collaborate-to-develop-a-frontier-ai-model-for-healthcare/
… -
Microsoft developing a frontier model for health
By
–
Microsoft is developing a frontier model for health